ES2131879T3 - Adyuvante para vacunas. - Google Patents

Adyuvante para vacunas.

Info

Publication number
ES2131879T3
ES2131879T3 ES95942006T ES95942006T ES2131879T3 ES 2131879 T3 ES2131879 T3 ES 2131879T3 ES 95942006 T ES95942006 T ES 95942006T ES 95942006 T ES95942006 T ES 95942006T ES 2131879 T3 ES2131879 T3 ES 2131879T3
Authority
ES
Spain
Prior art keywords
adjuvants
vaccines
repeating units
adjuvant
constitutive repeating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95942006T
Other languages
English (en)
Inventor
Luuk Hilgers
Michel Strebelle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dimminaco AG
Original Assignee
Dimminaco AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dimminaco AG filed Critical Dimminaco AG
Application granted granted Critical
Publication of ES2131879T3 publication Critical patent/ES2131879T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Devices For Use In Laboratory Experiments (AREA)

Abstract

ADYVANTES PARA VACUNAS QUE COMPRENDEN UN MEDIO LIQUIDO QUE CONTIENE POLIMEROS QUE TIENEN UNIDADES CONSTITUTIVAS REPETITIVAS AMIONICAS Y UNIDADES CONSTITUTIVAS REPETITIVAS HIDROFOBAS. LOS ADYUVANTES SON, VENTAJOSAMENTE, SOLUCIONES ACUOSAS DE ACIDOS POLIACRILICOS PARCIALMENTE ESTERIFICADOS. ESTOS NUEVOS ADYUVANTES SON MUY ESTABLES, EFICACES Y NO TIENEN MAS QUE UNA TOXICIDAD LOCAL RELATIVAMENTE BAJA. LA INVENCION SE REFIERE TAMBIEN A VACUNAS QUE INCLUYEN TALES ADYUVANTES ASI COMO UN PROCEDIMIENTO PARA SU FABRICACION.
ES95942006T 1994-12-27 1995-12-21 Adyuvante para vacunas. Expired - Lifetime ES2131879T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BE9401173A BE1008977A5 (fr) 1994-12-27 1994-12-27 Adjuvants pour vaccins.

Publications (1)

Publication Number Publication Date
ES2131879T3 true ES2131879T3 (es) 1999-08-01

Family

ID=3888559

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95942006T Expired - Lifetime ES2131879T3 (es) 1994-12-27 1995-12-21 Adyuvante para vacunas.

Country Status (15)

Country Link
US (1) US6340464B1 (es)
EP (1) EP0804234B1 (es)
JP (1) JP3817655B2 (es)
CN (1) CN1087177C (es)
AT (1) ATE180676T1 (es)
AU (1) AU713660B2 (es)
BE (1) BE1008977A5 (es)
BR (1) BR9510286A (es)
CA (1) CA2208860C (es)
DE (1) DE69510089T2 (es)
DK (1) DK0804234T3 (es)
ES (1) ES2131879T3 (es)
GR (1) GR3031103T3 (es)
SI (1) SI0804234T1 (es)
WO (1) WO1996020007A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9622159D0 (en) * 1996-10-24 1996-12-18 Solvay Sociutu Anonyme Polyanionic polymers as adjuvants for mucosal immunization
FR2776928B1 (fr) * 1998-04-03 2000-06-23 Merial Sas Vaccins adn adjuves
CL2008001806A1 (es) 2007-06-20 2008-09-05 Wyeth Corp Composicion de vacuna en emulsion agua en aceite que comprende un antigeno y un adyuvante en la fase acuosa; y metodo de elaboracion.
JP2018020962A (ja) * 2014-12-08 2018-02-08 エヌエーアイ株式会社 新規アジュバント
KR20190044052A (ko) * 2016-06-17 2019-04-29 메리얼 인코포레이티드 선형 또는 분지형 폴리아크릴산 폴리머 아쥬반트를 포함하는 신규한 면역원성 제형
CN110404064B (zh) * 2018-04-27 2023-06-16 洛阳赛威生物科技有限公司 一种禽用佐剂组合物及其制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE161050C (es) *
US3790665A (en) * 1968-02-23 1974-02-05 Haver Lockhart Labor Inc Injectable adjuvant,method of preparing same and compositions including such adjuvant
US3790655A (en) * 1971-03-02 1974-02-05 E B & A C Whiting Co Method for commingling and orienting colored sets of thermoplastic filaments
US3920811A (en) * 1972-12-22 1975-11-18 Cutter Lab Adjuvant compositions
US4340726A (en) * 1980-03-14 1982-07-20 Newport Pharmaceuticals International, Inc. Esters
US5047238A (en) * 1983-06-15 1991-09-10 American Home Products Corporation Adjuvants for vaccines
EP0273512B1 (en) * 1986-12-19 1991-02-27 Duphar International Research B.V Stabilised adjuvant suspension comprising dimethyl dioctadecyl ammonium bromide
US5565209A (en) * 1987-03-17 1996-10-15 Akzo Nobel N.V. Adjuvant mixture
DE3875762T2 (de) * 1987-03-17 1993-05-13 Akzo Nv Adjuvanzienmischung.
NZ239643A (en) * 1990-09-17 1996-05-28 North American Vaccine Inc Vaccine containing bacterial polysaccharide protein conjugate and adjuvant (c-nd-che-a-co-b-r) with a long chain alkyl group.
US5242686A (en) * 1990-11-07 1993-09-07 American Home Products Corporation Feline vaccine compositions and method for preventing chlamydia infections or diseases using the same
ZA929870B (en) * 1991-12-23 1993-08-18 Duphar Int Res Adjuvants
RU2137767C1 (ru) * 1994-04-22 1999-09-20 Сумитомо Кемикал Компани, Лимитед Эфирные соединения и средство для борьбы с вредными насекомыми

Also Published As

Publication number Publication date
JP3817655B2 (ja) 2006-09-06
CA2208860A1 (en) 1996-07-04
DK0804234T3 (da) 1999-11-15
AU713660B2 (en) 1999-12-09
CN1171053A (zh) 1998-01-21
WO1996020007A1 (fr) 1996-07-04
CN1087177C (zh) 2002-07-10
GR3031103T3 (en) 1999-12-31
DE69510089D1 (en) 1999-07-08
JPH11502191A (ja) 1999-02-23
AU4324796A (en) 1996-07-19
MX9704823A (es) 1998-06-30
SI0804234T1 (en) 1999-08-31
US6340464B1 (en) 2002-01-22
EP0804234B1 (fr) 1999-06-02
CA2208860C (en) 2009-03-17
EP0804234A1 (fr) 1997-11-05
ATE180676T1 (de) 1999-06-15
DE69510089T2 (de) 1999-09-23
BR9510286A (pt) 1997-11-11
BE1008977A5 (fr) 1996-10-01

Similar Documents

Publication Publication Date Title
DE69428795D1 (de) Phosphazene und polyelektrolyte als immunadjuvantien
EP0269926A3 (en) Lens usable in the ultraviolet
DE68910174T2 (de) Druckdichte Steckkupplung.
AU4324996A (en) Novel cyclodextrin-derivatives and methods for the preparation thereof
NO180668C (no) Kryss-bundede, sårsekretabsorberende hydrogeler
AU2876595A (en) Proteinaceous adjuvants
FI935804A0 (fi) Foerfarande foer papperstillverkning under anvaendande av tvaerbundna katjoniska/amfoteriska staerkelser
CA2236886A1 (en) Fiber optic gyroscope source wavelength control
DE69531793D1 (de) Immunogene zubereitungen
ES2112985T3 (es) Procedimiento y aparato para producir bobinas de estator enrolladas con forma.
ES2131879T3 (es) Adyuvante para vacunas.
AU5297999A (en) Use of a composition
DE69107990T2 (de) Hydraulisch angetriebene Hochdruckmembranpumpe.
PL320086A1 (en) Method of obtaining terpolymers
DE59100224D1 (de) Hoechstdruckplungerpumpe.
AU558008B2 (en) Ozone inactivated organisms as vaccines
FR2702655B1 (fr) Composition therapeutique nouvelle ayant un effet immunostimulant.
NO911922D0 (no) Fremgangsmaate for fremstilling av semi-ordnede polyamidimider.
RU96107439A (ru) Способ подготовки мягких контактных линз к применению
CA2079826A1 (en) Attenuated strains of aeromonas salmonicida useful as fish vaccines
IT9012449A1 (it) Procedimento per ottenere energia, utilizzando la pressione idrostatica di profondita'

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19980801

Kind code of ref document: R

Effective date: 19980801

FG2A Definitive protection

Ref document number: 804234

Country of ref document: ES